Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants

New England Journal of Medicine

Volumn 360, Issue 24, 2009, Pages 2544-2555

  Hirschfield, Gideon M ^a,b   Liu, Xiangdong ^a   Xu, Chun ^a   Lu, Yue ^g   Xie, Gang ^a   Lu, Yan ^a   Gu, Xiangjun ^g   Walker, Erin J ^a   Jing, Kaiyan ^g   Juran, Brian D ^h   Mason, Andrew L ^c   Myers, Robert P ^d   Peltekian, Kevork M ^e   Ghent, Cameron N ^f   Coltescu, Catalina ^b   Atkinson, Elizabeth J ^b,h   Heathcote, E Jenny ^a   Lazaridis, Konstantinos N ^h   Amos, Christopher I ^g   Siminovitch, Katherine A ^a,i  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h Mayo Clinic   (United States)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P35; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT4 PROTEIN; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 23;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BILIARY CIRRHOSIS; GENE; GENETIC ASSOCIATION; GENETICS;

GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA ANTIGENS; HLA-DQ ANTIGENS; HUMANS; INTERLEUKIN-12 RECEPTOR BETA 2 SUBUNIT; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-23; LIVER CIRRHOSIS, BILIARY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-12;

EID: 67149095289     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0810440     Document Type: Article

References (39)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261-1273 [Erratum, N Engl J Med 2006;354:313.]
2. Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330:1342-1347 (Pubitemid 24136057)
3. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008; 47:737-745 (Pubitemid 351280742)
4. Irie J, Wu Y, Wicker LS, et al. NOD. c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006;203:1209-1219 (Pubitemid 43736591)
5. Oertelt S, Lian ZX, Cheng CM, et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006;177:1655-1660 (Pubitemid 44092501)
6. Wakabayashi K, Lian ZX, Moritoki Y, et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 2006;44:1240-1249 (Pubitemid 44748374)
7. Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004;127: 485-492 (Pubitemid 39091897)
8. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999;30:402-407 (Pubitemid 29113227)
9. Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004;97: 397-406.
10. Lazaridis KN, Juran BD, Boe GM, et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 2007;46:785-792 (Pubitemid 47436125)
11. Donaldson PT, Baragiotta A, Heneghan MA, et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 2006;44:667-674 (Pubitemid 44433723)
12. Invernizzi P, Selmi C, Poli F, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008;48: 1906-1912
13. Donaldson P, Veeramani S, Baragiotta A, et al. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007;5:755-760 (Pubitemid 46830049)
14. Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Lazaridis KN. Primary biliary cirrhosis is associated with a genetic variant in the 3′ flanking region of the CTLA4 gene. Gastroenterology 2008;135:1200-1206
15. Walker EJ, Hirschfield GM, Xu C, et al. CTLA-4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum 2009;60:931-937
16. Heathcote EJ. Management of primary biliary cirrhosis: the American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005-1013
17. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-622 (Pubitemid 351601203)
18. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007;81:559-575 (Pubitemid 47330214)
19. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909 (Pubitemid 44141658)
20. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229 (Pubitemid 34680308)
21. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678 (Pubitemid 46889737)
22. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977-986 (Pubitemid 47367077)
23. Sigurdsson S, Nordmark G, Göring HH, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005;76:528-537 (Pubitemid 40250533)
24. Dideberg V, Kristjansdottir G, Milani L, et al. An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 2007;16:3008-3016 (Pubitemid 350131319)
25. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463 (Pubitemid 44871953)
26. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80:273-290 (Pubitemid 46175676)
27. Invernizzi P, Selmi C, Mackay IR, Podda M, Gershwin ME. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2005;3:401-410 (Pubitemid 40616904)
28. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005;37:357-364 [Erratum, Nat Genet 2005; 37:652.] (Pubitemid 40490485)
29. Traherne JA, Barcellos LF, Sawcer SJ, et al. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet 2006;15:155-161 (Pubitemid 43020113)
30. Mochida A, Kinouchi Y, Negoro K, et al. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502. Tissue Antigens 2007;70: 128-135 (Pubitemid 47028456)
31. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-864 (Pubitemid 47018195)
32. Goriely S, Neurath MF, Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 2008;8:81-86
33. Hoeve MA, Savage ND, de Boer T, et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 2006;36:661-670
34. Fung EY, Smyth DJ, Howson JM, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009;10:188-191
35. Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008;40:395-402.
36. Fisher SA, Tremelling M, Anderson CA, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008;40:710-712 (Pubitemid 351748865)
37. Airoldi I, Di Carlo E, Cocco C, et al. Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood 2005;106:3846-3853 (Pubitemid 41739022)
38. Pulickal AS, Hambleton S, Callaghan MJ, et al. Biliary cirrhosis in a child with inherited interleukin-12 deficiency. J Trop Pediatr 2008;54:269-271
39. Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006;18:347-361 [Erratum, Semin Immunol 2007;19:136-7.] (Pubitemid 44540199)